Search research articles
Contact Us
Filters
Showing results (171-180 of 228) with videos related to
Page
of 23
Sort By:
British Journal of Cancer
|
March 2, 2025
Prognostic relevance of the neurological symptom burden in brain metastases from breast cancer
Ariane Steindl, Clara Zach, Luzia Berchtold, et al.
Journal of Personalized Medicine
|
October 29, 2020
Targeted Therapy Recommendations for Therapy Refractory Solid Tumors-Data from the Real-World Precision Medicine Platform MONDTI
Hossein Taghizadeh, Matthias Unseld, Martina Spalt, et al.
Nature Reviews. Clinical Oncology
|
April 21, 2023
Understanding the activity of antibody-drug conjugates in primary and secondary brain tumours
Maximilian J Mair, Rupert Bartsch, Emilie Le Rhun, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
June 14, 2021
Androgen Receptor is Expressed in Breast Cancer Brain Metastases
Elisabeth S Bergen, Anna S Berghoff, Ariane Steindl, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 14, 2023
Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients
Kerstin Wimmer, Monika Sachet, Cristiano Ramos, et al.
Therapeutic Advances in Medical Oncology
|
May 17, 2021
Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumab
Elisabeth Sophie Bergen, Amelie Binter, Angelika Martina Starzer, et al.
Breast (Edinburgh, Scotland)
|
February 17, 2020
Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2- advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Primary results from the non-interventional study, STEPAUT
Guenther G Steger, Daniel Egle, Rupert Bartsch, et al.
Journal of Affective Disorders
|
August 5, 2023
Affective temperament, fatigue, and pain in cancer patients
Matthias Knefel, Elisabeth L Zeilinger, Andreas Erfurth, et al.
Breast Care (Basel, Switzerland)
|
March 12, 2015
Taxanes Plus Trastuzumab Compared To Oral Vinorelbine Plus Trastuzumab in HER2-Overexpressing Metastatic Breast Cancer
Elisabeth Bergen, Anna S Berghoff, Margaretha Rudas, et al.
Wiener Klinische Wochenschrift
|
September 23, 2022
Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update
Gabriel Rinnerthaler, Christian Singer, Edgar Petru, et al.
Page
of 23
Search research articles
Search
Showing results (171-180 of 228) with videos related to
Sort By:
Page
of 23
British Journal of Cancer
|
March 2, 2025
Prognostic relevance of the neurological symptom burden in brain metastases from breast cancer
Ariane Steindl, Clara Zach, Luzia Berchtold, et al.
Journal of Personalized Medicine
|
October 29, 2020
Targeted Therapy Recommendations for Therapy Refractory Solid Tumors-Data from the Real-World Precision Medicine Platform MONDTI
Hossein Taghizadeh, Matthias Unseld, Martina Spalt, et al.
Nature Reviews. Clinical Oncology
|
April 21, 2023
Understanding the activity of antibody-drug conjugates in primary and secondary brain tumours
Maximilian J Mair, Rupert Bartsch, Emilie Le Rhun, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
June 14, 2021
Androgen Receptor is Expressed in Breast Cancer Brain Metastases
Elisabeth S Bergen, Anna S Berghoff, Ariane Steindl, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 14, 2023
Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients
Kerstin Wimmer, Monika Sachet, Cristiano Ramos, et al.
Therapeutic Advances in Medical Oncology
|
May 17, 2021
Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumab
Elisabeth Sophie Bergen, Amelie Binter, Angelika Martina Starzer, et al.
Breast (Edinburgh, Scotland)
|
February 17, 2020
Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2- advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Primary results from the non-interventional study, STEPAUT
Guenther G Steger, Daniel Egle, Rupert Bartsch, et al.
Journal of Affective Disorders
|
August 5, 2023
Affective temperament, fatigue, and pain in cancer patients
Matthias Knefel, Elisabeth L Zeilinger, Andreas Erfurth, et al.
Breast Care (Basel, Switzerland)
|
March 12, 2015
Taxanes Plus Trastuzumab Compared To Oral Vinorelbine Plus Trastuzumab in HER2-Overexpressing Metastatic Breast Cancer
Elisabeth Bergen, Anna S Berghoff, Margaretha Rudas, et al.
Wiener Klinische Wochenschrift
|
September 23, 2022
Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update
Gabriel Rinnerthaler, Christian Singer, Edgar Petru, et al.
Page
of 23